Iris de Heer

1.2k total citations
20 papers, 240 citations indexed

About

Iris de Heer is a scholar working on Genetics, Developmental Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Iris de Heer has authored 20 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Developmental Neuroscience and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Iris de Heer's work include Glioma Diagnosis and Treatment (10 papers), Anesthesia and Neurotoxicity Research (7 papers) and Anesthesia and Sedative Agents (6 papers). Iris de Heer is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Anesthesia and Neurotoxicity Research (7 papers) and Anesthesia and Sedative Agents (6 papers). Iris de Heer collaborates with scholars based in Netherlands, Belgium and United States. Iris de Heer's co-authors include Frank Weber, Pim J. French, Thierry Gorlia, Johan M. Kros, Michael Weller, Martin J. van den Bent, Paul M. Clément, Henning Tiemeier, Sanne E. Hoeks and Filip De Vos and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Iris de Heer

19 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris de Heer Netherlands 8 111 55 50 47 44 20 240
Benjamin D. Gross United States 8 52 0.5× 22 0.4× 14 0.3× 70 1.5× 47 1.1× 25 244
Hirak Biswas India 6 6 0.1× 20 0.4× 36 0.7× 19 0.4× 117 2.7× 8 280
Wenjun Yang China 10 3 0.0× 27 0.5× 29 0.6× 41 0.9× 115 2.6× 19 334
Florian Liebl Germany 5 29 0.3× 8 0.1× 17 0.3× 50 1.1× 57 1.3× 5 346
Thorsten Dohrmann Germany 10 5 0.0× 5 0.1× 61 1.2× 96 2.0× 69 1.6× 23 304
Yutaka Fujioka Japan 11 193 1.7× 5 0.1× 61 1.3× 93 2.1× 48 321
Shunichiro Miki Japan 8 89 0.8× 7 0.1× 59 1.3× 63 1.4× 25 205
Julia Sun United States 7 126 1.1× 9 0.2× 56 1.2× 193 4.4× 8 331
Henry Knott United Kingdom 3 36 0.3× 4 0.1× 4 0.1× 10 0.2× 87 2.0× 3 170
Ismail Eralp Netherlands 8 7 0.1× 5 0.1× 13 0.3× 87 1.9× 231 5.3× 10 298

Countries citing papers authored by Iris de Heer

Since Specialization
Citations

This map shows the geographic impact of Iris de Heer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris de Heer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris de Heer more than expected).

Fields of papers citing papers by Iris de Heer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris de Heer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris de Heer. The network helps show where Iris de Heer may publish in the future.

Co-authorship network of co-authors of Iris de Heer

This figure shows the co-authorship network connecting the top 25 collaborators of Iris de Heer. A scholar is included among the top collaborators of Iris de Heer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris de Heer. Iris de Heer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hijfte, Levi van, Marjolein Geurts, Iris de Heer, et al.. (2025). Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma. Nature Communications. 16(1). 1156–1156. 2 indexed citations
3.
Hijfte, Levi van, C. Mircea S. Tesileanu, Iris de Heer, et al.. (2024). Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma. Acta Neuropathologica. 148(1). 50–50. 3 indexed citations
4.
Heer, Iris de & Frank Weber. (2023). Electroencephalographic Density Spectral Array monitoring in pediatric anesthesia: clinical background and practical applications. Minerva Anestesiologica. 89(4). 351–358. 5 indexed citations
5.
Niers, Johanna M., Wendy W.J. de Leng, Youri Hoogstrate, et al.. (2023). Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort. Neuro-Oncology Advances. 5(1). vdad149–vdad149. 2 indexed citations
6.
Kouwenhoven, Mathilde C.M., Iris de Heer, Birgit I. Lissenberg‐Witte, et al.. (2023). Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol. Journal of Neuro-Oncology. 162(1). 225–235. 5 indexed citations
7.
Heer, Iris de, et al.. (2023). Electroencephalographic density spectral array monitoring during propofol/sevoflurane coadministration in children, an exploratory observational study. Anaesthesia Critical Care & Pain Medicine. 43(2). 101342–101342. 3 indexed citations
9.
Balcıoğlu, Hayri E., Iris de Heer, Maurice de Wit, et al.. (2022). 3D‐Engineered Scaffolds to Study Microtubes and Localization of Epidermal Growth Factor Receptor in Patient‐Derived Glioma Cells. Small. 18(49). e2204485–e2204485. 22 indexed citations
10.
Heer, Iris de, et al.. (2021). Midlatency auditory evoked potentials during anesthesia in children: A narrative review. Pediatric Anesthesia. 31(10). 1031–1039.
11.
Wit, Maurice de, Ya Gao, Iris de Heer, et al.. (2020). Mutation and drug-specific intracellular accumulation of EGFR predict clinical responses to tyrosine kinase inhibitors. EBioMedicine. 56. 102796–102796. 11 indexed citations
12.
14.
French, Pim J., Marica Eoli, Juan Manuel Sepúlveda-Sánchez, et al.. (2019). Defining EGFR amplification status for clinical trial inclusion. Neuro-Oncology. 21(10). 1263–1272. 28 indexed citations
15.
Bent, Martin J. van den, Martin Klein, Marion Smits, et al.. (2018). Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial. The Lancet Oncology. 19(9). 1170–1179. 82 indexed citations
19.
Bent, Martin J. van den, Martin Klein, Marion Smits, et al.. (2017). Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion.. Journal of Clinical Oncology. 35(15_suppl). 2009–2009. 6 indexed citations
20.
Heer, Iris de, Henning Tiemeier, Sanne E. Hoeks, & Frank Weber. (2016). Intelligence quotient scores at the age of 6 years in children anaesthetised before the age of 5 years. Anaesthesia. 72(1). 57–62. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026